Experimental group:fluzoparib

2 trials

Sponsors

Harbin Medical University Cancer Hospital, The Second Hospital of Shandong University

Conditions

SCLCpancreatic cancer

Phase 2

A prospective clinical study of fluzopab in the treatment of pancreatic cancer

Active, not recruitingChiCTR2200058787

Harbin Medical University Cancer Hospitalpancreatic cancer

Start: 2022-04-15Updated: 2024-01-22

Fluzoparib as first-line maintenance therapy for extensive-stage small cell lung cancer is effective: a phase II clinical study

Active, not recruitingChiCTR2200060985

The Second Hospital of Shandong UniversitySCLC

Start: 2022-06-01Updated: 2023-03-26